Southern Medical University, Zhujiang Hospital
Guangzhou, Guangdong, 510282, China
NCT Number: NCT03133598
Un-ruptured intracranial aneurysm is a complex disease that seriously affects human life and health. At present, the treatment of intracranial aneurysm is divided into interventional treatment and craniotomy clipping, the two treatment methods are different in the intervention effect of aneurysm, for example, the complications of interventional therapy are lower than craniotomy clipping, but the long-term patency rate is lower than craniotomy clipping, and there is no standard of treatment in different parts of aneurysm in our country, the choice of intervention measures of un-ruptured aneurysm is different in different clinical centers; on the other hand, there are serious problems in the treatment of aneurysms, because without the relevant guidelines of diagnosis and treatment of intracranial aneurysms, different clinical centers will cause excessive treatment of un-ruptured aneurysms, not only bring unreasonable utilization of medical resources, but also cause the subject's life and property to be threatened.
The patients with un-ruptured intracranial aneurysm(estimated sample number over 1500) were included in prospective cohort study, after clipping and intervention operation, setting fixed time for postoperative follow-up, the clinical data and image data were recorded, the safety, efficacy and economic benefits of interventional treatment and craniotomy clipping were compared, providing strategies for the standardized treatment of un-ruptured intracranial aneurysms.
Looking for future studies?
Notify Me14 year–80 year
All sexes
Observational
Guangzhou, Guangdong, 510282, China
For this study,investigators consulted and hired professionals and experts about data collection, data and methodology,including Data Monitoring Committee, Data Management Committee, Progect Academic Committee, Executive Group, Project Manager, Project Statistician,Technical Support Center. investigators have a scientific regulations for this project. Project Manager and Executive Group: To ensure the successfully implementation of this project, including charging the daily operations of the study in 20 different research hospitals, organizing the monthly meeting to consider issures raised during the monthly progress of the study, liaising with the steering committee,the data management centre and statistical centre. Data management Committee: To be responsible for setting up and maintain the Electronic Data Capture (EDC) System according to the papera Case Report Form(pCRF) designed by principal investigators. To collect and save the pCRF coming from sub-centers. To entry the data into EDC system and keep the same with CRF. To organize training for the investigators about the rules in filling the EDC and pCRF.To determine the frequency of the Data Management Report and to fed it back to the steering committee every three months. Data Mornitoring Committee: To determine the frequency of the data mornitoring including the source data(Medical records) accuracy, completeness and representativeness comparing the external data(EDC, pCRF) in participanted centers.
To report the results after the mornitoring back to the steering committee about the missing data, non-reported and other problems about the study. To make a Standard Operation Procedure(SOP) from getting data to using data. Academic Committee: To supervise the academic issues including patient recruitment, protocol deviation, adverse events evalutating. To settle down the question and problem in the process of the study. Project Statistician: We cooperate with the statisticians of Medical Research & Biometrics Center National Center for Cardiovascular Diseases, China to get the perfessional statistical report. Technical Support Center:To provide technical support during the process of the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months later after operation.
The safety evaluation including the mortality(mRS=6) rate and disability(2<mRS<6) rate of subjects.
Time frame: 6 months later after operation.
The effectiveness evaluation including the complete occlusion(Raymond classification=1) rate of aneurysms.
Time frame: 1 year
0 completely silent
Time frame: 1 year
Time frame: 6 months later after operation.
The effectiveness evaluation including the recurrence(Raymond classification=3) rate of aneurysms.
Time frame: up to 24 months
The safety evaluation including the mortality(mRS=6) rate and disability(2<mRS<6) rate of subjects.
Time frame: up to 24 months
The effectiveness evaluation including the complete occlusion(Raymond classification=1) rate of aneurysms.
Time frame: up to 24 months
angiography revealed total or near total occlusion of aneurysm in 6 months after operation, no recurrence of aneurysm was found, the treatment was considered successful.
Time frame: up to 24 months
cerebrovascular complications including any intracranial hemorrhage, ischemia, or death
Time frame: up to 24 months
All costs associated with treatment
Zhujiang Hospital
Other
Prospective Cohort Study of Interventional Therapy and Craniotomy for Unruptured Aneurysms
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06303063
Aneurysm, Brain Diseases
Beijing, China
View Trial DetailsNCT04380350
Aneurysm, Brain Diseases
Salzburg, Austria
View Trial DetailsNCT07500155
AV Fistula, AVM - Cerebral Arteriovenous Malformation
Xingtai, China
View Trial DetailsNCT04518670
Aneurysm, Brain Diseases
Mobile, Alabama, United States
View Trial Details